Drug recall · February 28, 2024
Oseltamivir Phosphate for Oral Suspension 6mg/ml recall
Why: Failed Impurities/Degradation Specifications: Out-of-specification test results.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
- Lots / codes
Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024
- Quantity
- 46,037 Bottles
- Company
- Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
- Distribution
- Nationwide in the USA
- Initiated
- February 13, 2024 · Voluntary: Firm initiated
- Classified
- February 16, 2024
- Reported
- February 28, 2024
- Ended
- February 14, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oseltamivir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.